AZTA
Price
$26.05
Change
+$0.69 (+2.72%)
Updated
Jul 13 closing price
Capitalization
1.2B
29 days until earnings call
Intraday BUY SELL Signals
ILMN
Price
$190.05
Change
-$0.15 (-0.08%)
Updated
Jul 13 closing price
Capitalization
28.75B
17 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

AZTA vs ILMN

AZTA vs ILMN Comparison Chart in %
loading
loading
View a ticker or compare two or three
VS
AZTA vs. ILMN commentary
Jul 14, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AZTA is a Buy and ILMN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 14, 2026
Stock price -- (AZTA: $26.05 vs. ILMN: $190.05)
Brand notoriety: AZTA: Not notable vs. ILMN: Notable
AZTA represents the Pharmaceuticals: Other, while ILMN is part of the Medical Specialties industry
Current volume relative to the 65-day Moving Average: AZTA: 36% vs. ILMN: 34%
Market capitalization -- AZTA: $1.2B vs. ILMN: $28.75B
AZTA [@Pharmaceuticals: Other] is valued at $1.2B. ILMN’s [@Medical Specialties] market capitalization is $28.75B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $144.19B to $0. The market cap for tickers in the [@Medical Specialties] industry ranges from $3.82T to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $7.98B. The average market capitalization across the [@Medical Specialties] industry is $17.16B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AZTA’s FA Score shows that 0 FA rating(s) are green whileILMN’s FA Score has 3 green FA rating(s).

  • AZTA’s FA Score: 0 green, 5 red.
  • ILMN’s FA Score: 3 green, 2 red.
According to our system of comparison, ILMN is a better buy in the long-term than AZTA.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AZTA’s TA Score shows that 5 TA indicator(s) are bullish while ILMN’s TA Score has 4 bullish TA indicator(s).

  • AZTA’s TA Score: 5 bullish, 4 bearish.
  • ILMN’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, AZTA is a better buy in the short-term than ILMN.

Price Growth

AZTA (@Pharmaceuticals: Other) experienced а +1.48% price change this week, while ILMN (@Medical Specialties) price change was -2.20% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was -2.39%. For the same industry, the average monthly price growth was +7.29%, and the average quarterly price growth was -8.66%.

The average weekly price growth across all stocks in the @Medical Specialties industry was -3.19%. For the same industry, the average monthly price growth was +9.26%, and the average quarterly price growth was +1.11%.

Reported Earning Dates

AZTA is expected to report earnings on Aug 11, 2026.

ILMN is expected to report earnings on Jul 30, 2026.

Industries' Descriptions

@Pharmaceuticals: Other (-2.39% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

@Medical Specialties (-3.19% weekly)

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
ILMN($28.8B) has a higher market cap than AZTA($1.2B). AZTA has higher P/E ratio than ILMN: AZTA (42.43) vs ILMN (34.55). ILMN YTD gains are higher at: 44.899 vs. AZTA (-21.678). ILMN has higher annual earnings (EBITDA): 1.43B vs. AZTA (36.6M). ILMN has more cash in the bank: 1.16B vs. AZTA (381M). AZTA has less debt than ILMN: AZTA (55.7M) vs ILMN (2.54B). ILMN has higher revenues than AZTA: ILMN (4.39B) vs AZTA (596M).
AZTAILMNAZTA / ILMN
Capitalization1.2B28.8B4%
EBITDA36.6M1.43B3%
Gain YTD-21.67844.899-48%
P/E Ratio42.4334.55123%
Revenue596M4.39B14%
Total Cash381M1.16B33%
Total Debt55.7M2.54B2%
FUNDAMENTALS RATINGS
AZTA vs ILMN: Fundamental Ratings
AZTA
ILMN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
50
Fair valued
75
Overvalued
PROFIT vs RISK RATING
1..100
100100
SMR RATING
1..100
9530
PRICE GROWTH RATING
1..100
564
P/E GROWTH RATING
1..100
865
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

AZTA's Valuation (50) in the Electronic Production Equipment industry is in the same range as ILMN (75) in the Biotechnology industry. This means that AZTA’s stock grew similarly to ILMN’s over the last 12 months.

AZTA's Profit vs Risk Rating (100) in the Electronic Production Equipment industry is in the same range as ILMN (100) in the Biotechnology industry. This means that AZTA’s stock grew similarly to ILMN’s over the last 12 months.

ILMN's SMR Rating (30) in the Biotechnology industry is somewhat better than the same rating for AZTA (95) in the Electronic Production Equipment industry. This means that ILMN’s stock grew somewhat faster than AZTA’s over the last 12 months.

ILMN's Price Growth Rating (4) in the Biotechnology industry is somewhat better than the same rating for AZTA (56) in the Electronic Production Equipment industry. This means that ILMN’s stock grew somewhat faster than AZTA’s over the last 12 months.

ILMN's P/E Growth Rating (5) in the Biotechnology industry is significantly better than the same rating for AZTA (86) in the Electronic Production Equipment industry. This means that ILMN’s stock grew significantly faster than AZTA’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
AZTAILMN
RSI
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
67%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
73%
Bearish Trend 4 days ago
73%
Momentum
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
74%
MACD
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
75%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
80%
Bullish Trend 4 days ago
69%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
74%
Bullish Trend 4 days ago
74%
Advances
ODDS (%)
Bullish Trend 18 days ago
70%
Bullish Trend 12 days ago
70%
Declines
ODDS (%)
Bearish Trend 21 days ago
82%
Bearish Trend 27 days ago
79%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
71%
Bearish Trend 4 days ago
68%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bullish Trend 4 days ago
79%
View a ticker or compare two or three
Interact to see
Advertisement
AZTA
Daily Signal:
Gain/Loss:
ILMN
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
FISEX36.67N/A
N/A
Franklin Equity Income A
ERLVX30.89N/A
N/A
Eaton Vance Large-Cap Value R6
JOPPX56.75N/A
N/A
Johnson Opportunity
BDAIX34.67-0.35
-1.00%
Baron Durable Advantage Institutional
RICGX67.95-0.75
-1.09%
American Funds Invmt Co of Amer R-6

ILMN and

Correlation & Price change

A.I.dvisor indicates that over the last year, ILMN has been loosely correlated with BRKR. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if ILMN jumps, then BRKR could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ILMN
1D Price
Change %
ILMN100%
-0.08%
BRKR - ILMN
60%
Loosely correlated
-1.81%
RVTY - ILMN
58%
Loosely correlated
-1.05%
AZTA - ILMN
51%
Loosely correlated
+2.72%
A - ILMN
50%
Loosely correlated
-0.19%
BIO - ILMN
50%
Loosely correlated
+0.50%
More